+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


InMed Pharmaceuticals Inc (IN) - Financial and Strategic SWOT Analysis Review

  • ID: 4281499
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. The company's pipeline products include INM-750 and INM-085. Its products are used for the treatment of glaucoma, ocular allergies, arthritis, cancer and skin diseases, epidermolysis bullosa, psoriasis and pemphigus vulgaris metabolic syndrome, among others. InMed uses its proprietary platform technology to discover new bioactive compounds within the cannabis plant that interact with certain genes responsible for specific diseases. The company works in partnership with University of British Columbia and University of Debrecen. InMed is headquartered in Vancouver, British Columbia, Canada.

InMed Pharmaceuticals Inc Key Recent Developments

Mar 06, 2018: Relievant Appoints Christopher Geyen Chief Financial Officer
Mar 06, 2018: InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research
Mar 02, 2018: InMed Receives Conditional Approval to List on the Toronto Stock Exchange
Nov 16, 2017: InMed to Present at Cannabis-Based Science & Medicine Conference
Oct 24, 2017: InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid

This comprehensive SWOT profile of InMed Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of InMed Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • InMed Pharmaceuticals Inc - Key Information
  • InMed Pharmaceuticals Inc - Overview
  • InMed Pharmaceuticals Inc - Key Employees
  • InMed Pharmaceuticals Inc - Key Employee Biographies
  • InMed Pharmaceuticals Inc - Key Operational Heads
  • InMed Pharmaceuticals Inc - Major Products and Services
  • InMed Pharmaceuticals Inc - History
  • InMed Pharmaceuticals Inc - Company Statement
  • InMed Pharmaceuticals Inc - Locations And Subsidiaries
  • InMed Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • InMed Pharmaceuticals Inc - Business Description
  • InMed Pharmaceuticals Inc - Corporate Strategy
  • InMed Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • InMed Pharmaceuticals Inc - Strengths
  • InMed Pharmaceuticals Inc - Weaknesses
  • InMed Pharmaceuticals Inc - Opportunities
  • InMed Pharmaceuticals Inc - Threats
  • InMed Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • InMed Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • InMed Pharmaceuticals Inc, Key Information
  • InMed Pharmaceuticals Inc, Key Ratios
  • InMed Pharmaceuticals Inc, Share Data
  • InMed Pharmaceuticals Inc, Major Products and Services
  • InMed Pharmaceuticals Inc, History
  • InMed Pharmaceuticals Inc, Key Employees
  • InMed Pharmaceuticals Inc, Key Employee Biographies
  • InMed Pharmaceuticals Inc, Key Operational Heads
  • InMed Pharmaceuticals Inc, Other Locations
  • InMed Pharmaceuticals Inc, Subsidiaries
  • InMed Pharmaceuticals Inc, Key Manufacturing facilities
  • InMed Pharmaceuticals Inc, Key Competitors
  • InMed Pharmaceuticals Inc, SWOT Analysis
  • InMed Pharmaceuticals Inc, Ratios based on current share price
  • InMed Pharmaceuticals Inc, Annual Ratios
  • InMed Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • InMed Pharmaceuticals Inc, Performance Chart
  • InMed Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown